Photo of Henry Sacks

Henry Sacks

  • PROFESSOR Preventive Medicine
  • PROFESSOR Medicine, Infectious Diseases
  • PROFESSOR Pediatrics
  • PROFESSOR Geriatrics and Palliative Medicine
  • PROFESSOR Oncological Sciences
  • PROFESSOR Biomathematical Sciences
Print ProfilePrint Profile



  • Geriatric Medicine

  • Infectious Disease

  • American Board of Internal Medicine


  • MD, Albany Medical College

  • Ph.D., Albany Medical College

  • Internship, General Medicine
    University of Connecticut

  • Residency, Internal Medicine
    University of Connecticut

  • Fellowship, Infectious Diseases
    University of Connecticut


    Dr. Sacks is the Director of the Thomas C. Chalmers Clinical Trials Unit.


Dr. Sacks originally came to Mount Sinai to work with Thomas C. Chalmers, a pioneer in what is now called "evidence-based medicine." His work has been in two categories: 1) the design, conduct and analysis of clinical and natural history studies (primary studies), to provide new data to directly answer clinical questions, and 2) synthesis of existing data by meta-analysis, decision analysis and cost-effectiveness analysis, to provide guidance for urgent clinical problems for which primary data are not (or not yet) available. Dr. Sacks' current research interests include clinical trials, infections in the elderly, HIV, complementary and alternative therapies.

Dr. Sacks is also Director for Clinical Research of Mount Sinai's Complementary and Alternative Medicine (CAM) Center, and co-director of Mount Sinai's Fogarty International AIDS Training program.


Dunn AS, Wisnivesky J, Ho W, Moore C, Mcginn T, Sacks HS. Perioperative management of patients on oral anticoagulants: a decision analysis. Med Decis Making 2005 Jul-Aug;: 387-397.

Rovetto AL, Lai CY, Sacks H. Cost-Effectiveness of Probiotic Treatment in Preventing Hospital-Acquired Clostridium Difficile-Associated Diarrhea.;.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Sacks during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Scientific Advisory Board:

  • Wyeth (Pfizer, Inc.)

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.

Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.

Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central


19 East 98th Street Room Suite 4B
New York, NY 10029

Tel: 212-241-7856
Fax: 212-860-4607
19 East 98th Street

19 East 98th Street
Infectious Disease Associates
New York, NY 10029

Tel: 212-241-7856
Fax: 212-860-4607
Get Directions

Office Hours:
  • Monday 9:00am - 5:00pm
  • Tuesday 12:00pm - 5:00pm
  • Wednesday 9:00am - 5:00pm
  • Thursday 9:00am - 5:00pm
  • Friday 9:00am - 12:00pm